Biotech Vivet Therapeutics Presents Interim Data from its Phase 1/2 GATEWAY Trial for the Treatment of Wilson Disease at EASL Congress 2024 June 5, 2024
Biotech Global Direct-to-Consumer Testing Industry Forecasted to Grow at 12.5% CAGR, Reaching $3.2 Billion by 2029 June 5, 2024
Biotech Perfect Diary’s Parent Company Yatsen Group Officially Unveils Global Innovation and R&D Center June 5, 2024
Biotech Department of Health – Abu Dhabi and Opus Genetics Announce Collaboration to Advance Ground-Breaking Gene Therapy Research for Inherited Retinal Diseases June 5, 2024
Biotech Enzymes Market worth $20.4 billion by 2029 – Exclusive Report by MarketsandMarkets™ June 4, 2024
Biotech EMA Grants Orphan Drug Designation to NeoImmuneTech’s NT-I7 for the Treatment of Acute Radiation Syndrome June 4, 2024
Biotech MicroAlgo Inc. (NASDAQ: MLGO) Announced to Jointly Establish a Micro-Consciousness Quantum Research Center With WIMI (NASDAQ: WIMI) June 4, 2024
Biotech Department of Health – Abu Dhabi Partners with Pfizer to Advance Research in Sickle Cell Disease and Beyond June 4, 2024
Biotech IDEAYA Announces Results for Darovasertib Phase 2 IST in Neoadjuvant Uveal Melanoma at ASCO and Clinical Update for Phase 2 Company-Sponsored Neoadjuvant Study June 3, 2024